More on BGNE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (7.4 Score)
- Holders

Upcoming Events

- Earnings (5/9/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BeiGene (NQ:BGNE)
Delayed: 184.71 --0 (-0%)
Prev. Close $184.71  
Open$184.71 
52 Wk High$36.76 
52 Wk Low$22.51 
Day High$184.71 
Day Low$184.71 
P/E N/A  
EPS$0.00 
Volume3,787,779 

Friends, Peers and Foes (?): 6160:HK LH (more...)

Mar 3, 2026 08:05 AM BeiGene, Ltd. (6160:HK) (BGNE) PT Lowered to HK$286.20 at CLSA
Feb 27, 2026 08:00 PM This Chinese oncology drugmaker is set for catalyst-heavy 2026
Feb 13, 2026 07:33 AM BeiGene, Ltd. (6160:HK) (BGNE) PT Raised to HK$263.69 at Nomura/Instinet
Nov 7, 2025 04:48 AM BeiGene, Ltd. (6160:HK) (BGNE) PT Raised to HK$288 at CLSA
Sep 8, 2025 05:16 AM BeiGene, Ltd. (6160:HK) (BGNE) PT Raised to HK$236 at Macquarie
Aug 7, 2025 07:29 AM BeiGene, Ltd. (6160:HK) (BGNE) PT Raised to HK$264.40 at CLSA
Aug 7, 2025 06:45 AM BeiGene, Ltd. (6160:HK) (BGNE) PT Raised to HK$217.94 at Nomura/Instinet
Jul 18, 2025 05:22 AM BeiGene, Ltd. (6160:HK) (BGNE) PT Raised to HK$209.92 at Nomura/Instinet
View All Articles

Entities mentioned with BGNE

View All Entities